Cerebrovascular Endothelial Dysfunction: Role of BACE1

Area of Science:

• Neuroscience
• Cardiovascular Biology
• Cellular Biology

Background:

• Endothelial dysfunction links cardiovascular risk factors to dementia, including Alzheimer's disease.
• BACE1 (β-site amyloid precursor protein-cleaving enzyme 1) initiates amyloid-β peptide production, implicated in Alzheimer's pathogenesis.
• Excessive BACE1 activation detrimentally affects endothelial function through both amyloid-β-dependent and -independent pathways.

Purpose of the Study:

• To review evidence linking excessive BACE1 activation in cerebrovascular endothelium to impaired brain blood vessel function.
• To explore the mechanisms underlying BACE1-induced endothelial dysfunction.
• To highlight the therapeutic implications of understanding BACE1's role in cerebrovascular health.

Main Methods:

• Critical evaluation of existing scientific literature.
• Analysis of studies investigating BACE1 activity in endothelial cells.
• Synthesis of evidence on BACE1's impact on cerebrovascular homeostasis.

Main Results:

• High local amyloid-β concentrations in brain vasculature disrupt endothelial protective functions.
• Endothelial BACE1's Aβ-independent proteolytic activity significantly contributes to endothelial dysfunction.
• Excessive BACE1 activation impairs essential homeostatic functions of brain blood vessels.

Conclusions:

• BACE1 overactivation in cerebrovascular endothelium is a key factor in endothelial dysfunction and dementia pathogenesis.
• Targeting BACE1 offers potential therapeutic strategies for protecting cerebrovascular function.
• Further research into BACE1 mechanisms can guide the development of novel treatments for neurodegenerative diseases.